FDA Peptide Reclassification 2026: What It Means for Providers The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health A Turning Point for Peptides? What RFK Jr.'s Announcement Could Mean for the Future of Wellness and Longevity Skytale Group FDA mulls compounding for peptides previously flagged over safety risks BioSpace BULK DRUG SUBSTANCES AND FDA EVALUATION